Introduction: SARS Covid II pandemic has consistently spread and has severely disrupted the lives of more than the three quarters of the world’s population. Their system is unable to effectively respond to the current challenges in the present day pandemic, which has put forth another challenge for medical educators across the world to deal with the huge responsibility of rethinking how to carry on delivering high quality medical education due to social isolation strategies and enormous clinical responsibilities. Webinars have become an essential component of Physiotherapy teaching during the pandemic periods. Lecturers have reported about satisfaction and enjoyable sessions during webinars. Materials and Method: An intern’s physiotherapy attitude form, student’s satisfaction questionnaire, smooth delivery and intuitive interface scores were dependent variables and Teaching Method (participation in a webinar or classroom teaching) is the independent variable. Result: Descriptive analysis and Students t-test were done for inter-group comparison of Webinar Group Vs Classroom group which were found to be statistically significant at p≤0.5. The scores for Webinar group vs Classroom group respectively are Physiotherapy attitude questionnaire Test scores (54.17±8.8 & 39.38±10.8, t=5.7*), Student’s satisfaction questionnaire scores (4.54±0.59 & 4.29±0.69, t=1.45), Smooth Delivery Scores (4.5±0.5 & 5.0±0, t= 4.79*), Students intuitive interface scores (4.63±0.4 & 3.04±0.2 t=13.2*) and Action taken scores (4.58±0.4 & 3.25±0.43, t=11.56*). Conclusion: The webinar based teaching is more effective as compared to classroom teaching for Physiotherapy Interns with a limitation to teaching practical skills especially in fields like Physiotherapy where it is essential.
More than 12 million people have been infected with COVID-19 worldwide, with more than 500,000 deaths to date.1 Although COVID-19 research is rapidly evolving, new findings must be thoroughly scrutinised before any conclusions or treatment protocols are established or amended.2 Although COVID-19 is most usually associated with respiratory symptoms such as cough and dyspnea; it has recently been associated with a neurotropic presentation.3 Guillain-Barré Syndrome (GBS) is best described as an acute inflammatory polyradiculoneuropathy clinically characterized by areflexia and progressive weakness of arms and legs. Though, many rare variants of GBS have been described, the commonly observed subtypes such as Acute Motor Axonal Neuropathy (AMAN), Acute Motor Sensory Axonal Neuropathy (AMSAN) and Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) tend to fulfil the above-mentioned criteria.4 Recently, several case reports have suggested a relationship between the occurrence of Guillain-Barré syndrome (GBS) and a previous SARS-CoV-2 infection, which preceded the GBS onset by up to 4 weeks. Therefore, a post-infectious dysregulation of the immune system, triggered by SARS- CoV2, appears to be the most probable cause COVID-19 is a systemic disorder presenting typically with fever and respiratory symptoms but neurological manifestations such as acute cerebrovascular diseases, seizures, ageusia, anosmia meningitis, encephalitis and skeletal muscle involvement were soon reported.5 More recently, an increase in case reports of Guillain-Barré syndrome (GBS) in people infected with SARS-CoV-2 has prompted concerns about a possible link.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.